Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2024

Mar 5, 2024

30826_dirs_2024-03-04_0c6f5d87-c6e7-4e60-b1f0-d8f5eda11c54.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2024-02-29

Reporting Person: Hunt Anthony (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-29 Common Stock A 2504 $0.00 Acquired 216530 Direct
2024-03-01 Common Stock F 3322 $191.79 Disposed 213208 Direct

Footnotes

F1: Represents 2,504 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on February 24, 2021. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.

F2: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.